KEROS THERAPEUTICS, INC.

Insiders Keros Therapeutics, Inc.

Equities

KROS

US4923271013

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-09 EDT			5-day change	1st Jan Change
57.6 ^USD	-1.10%		+0.88%	+44.87%

05-08	Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000	MT
03-19	Morphic Holding Names Simon Cooper as Chief Medical Officer	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morphic Holding Names Simon Cooper as Chief Medical Officer	03-19	MT
Keros Therapeutics, Inc. Announces Resignation of Simon Cooper, M.B.B.S., as Chief Medical Officer, Effective March 12, 2024	03-05	CI
Insider Sell: Keros Therapeutics	23-06-12	MT
Keros Therapeutics, Inc Appoints Alpna Seth to its Board of Directors and Member of the Compensation Committee, Effective May 1, 2023	23-04-19	CI
Insider Sell: Keros Therapeutics	22-07-19	MT
Insider Sell: Keros Therapeutics	22-04-13	MT
Insider Sell: Keros Therapeutics	22-04-08	MT
Insider Sell: Keros Therapeutics	22-03-15	MT
Keros Therapeutics Names Christopher Rovaldi as COO	22-01-31	MT
Keros Therapeutics, Inc. Appoints Christopher Rovaldi as Chief Operating Officer	22-01-31	CI
Insider Sell: Keros Therapeutics	22-01-06	MT
Insider Sell: Keros Therapeutics	21-10-21	MT
Insider Sell: Keros Therapeutics	21-10-19	MT
Insider Sell: Keros Therapeutics	21-09-29	MT
Keros Therapeutics, Inc. Announces Executive Changes	21-08-02	CI
Keros Therapeutics, Inc. Announces Board Changes	20-12-17	CI
Keros Therapeutics Appoints Keith Regnante as Chief Financial Officer	20-02-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW